Back
 
Name: Dr. Salman Khan
Designation: Assistant Professor
Department: Pharmacy


Qualifications: PhD (SNU, South Korea), Post Doc (SNU, South Korea), Post Doc (McGill Univ., Canada)


Phone: +92-51 9064-4056
Email: skhan@qau.edu.pk
Status: On Job
Other Weblink: https://scholar.google.com.pk/citations?hl=en&user=dfYfFCgAAAAJ&view_op=list_works&sortby=pubdate


Research Interests Publications Conferences Research Projects

Neuropharmacology & Analgesia, Immuno-Molecular Pharmacology, Biochemical-Systemic Pharmacology

Author (s), title

Journal, Vol. No., Page No., Country

Year

Impact factor

1.      J Ali, A Khan, FA Shah, H Ali, S Islam , YS Kim  and Salman Khan. Mucoprotective effects of Saikosaponin-A in 5-fluorouracil-induced intestinal mucositis in mice model.

Life Sciences

LFS-D-19-02710R1

ACCEPTED

USA

2019

3.44

2.      R Afridi, A Khan, S Khalid, B Shal, H Rasheed, MZ Ullah, O Shehzad, YS Kim & Salman Khan.  Anti-hyperalgesic properties of a flavanone derivative Poncirin in acute and chronic inflammatory pain models in mice.

BMC Pharmacology and Toxicology, volume 20, Article number: 57

UK

2019

2.1

3.      Q Ain, M Zeeshan, Salman Khan, H Ali. Biomimetic hydroxyapatite as potential polymeric nanocarrier for the treatment of rheumatoid arthritis.

 

Journal of Biomedical Materials Research -

Part A, doi.org/10.1002/jbm.a.36765

USA

August 2019

3.22

 

4.      A Khan, Salman Khan, H Ali, KvShah, H Ali, O Shehzad, A Onder, YS Kim. Anomalin attenuates LPS-induced acute lungs injury through inhibition of AP-1 signaling

International Immunopharmacology 73 (2019) 451–460

USA

May, 2019

3.361

 

5.      S Zeeshan, M Naveed, A Khan, A Atiq, M Arif, MN Ahmed, YS Kim, Salman Khan. N-Pyrazoloyl and N-thiopheneacetyl hydrazone of isatin exhibited potent anti-inlammatory and anti-nociceptive properties through suppression of NF-κB, MAPK and oxidative stress signaling in animal models of inflammation

Inflammation Research 68:613–632

Canada

May 2019

3.061

6.      M Saqlain, A Riaz, MN Malik, Salman Khan, Al Ahmed, S Kamran, H Ali. Medication adherence and its association with health literacy and performance in activities of daily livings among elderly hypertensive patients.

Medicina 55, 163; doi:10.3390/medicina55050163

Republic of Lithuania

May 2019

1.467

7.      M Zeeshan,  H Ali, M Arshad, M Ijaz Khan,  M Mukhtar,  Salman Khan. Glycyrrhizic acid loaded pH-sensitive PLGA nanoparticles for the amelioration of inflammatory bowel disease

Nanomedicine

NNM-2018-0415

doi.org/10.2217/nnm-2018-0415

Accepted

2019

4.717

8.      S Khalid, A Khan, B Shal, H Ali, YS Kim, Salman Khan. Suppression of TRPV1 and P2Y nociceptors by honokiol isolated from Magnolia officinalis in 3rd degree burn mice by inhibiting inflammatory mediators.

Biomedicine & Pharmacotherapy

Volume 114, 108777

 

June, 2019

3.743

9.      M Naveed, A Khan, B Shal, S Zeeshan, A Khan, B Shal, A Atiq, H Ali, R Ullah, Zia Rehman, Salman Khan. A new cationic palladium (II) dithiocarbamate exhibits anti-inflammatory, analgesic and antipyretic activities through inhibition of inflammatory mediators in in vivo models.

Naunyn-Schmiedeberg’s Archives of Pharmacology (2019) 392:961–977

March 09, 2019

2.058

10.  B Shal, A Khan, M Naveed, N Khan, I Haq, SD Al-Sharari , YS Kim, Salman Khan. Effect of 25-methoxy hispidol A isolated from Poncirus trifoliate against bacteria-induced anxiety and depression by targeting neuroinflammation, oxidative stress and apoptosis in mice.

Biomedicine & Pharmacotherapy

111, 209-223. USA

 

March, 2019

3.743

11.  M Zeeshan, H Ali, Salman Khan, SA Khan, B Weigmann. Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease. 

International Journal of Pharmaceutics. 10;558:201-214. France

March, 2019

4.213

12.  A Khan, B Shal, M Naveed, FA Shah, A Atiq, N Ullah Khan, YS Kim, Salman Khan. Matrine ameliorates anxiety and depression-like behaviour by targeting hyperammonemia-induced neuroinflammation and oxidative stress in CCl4 model of liver injury

Neurotoxicology. 8;72:38-50.  USA

February, 2019

3.263

13.  A Khan, M Zia Ullah, R Afridi, H Rasheed, S Khalid, H Ullah, H Ali, S AlSharari, Y S Kim, Salman Khan. Antinociceptive properties of 25‐methoxy hispidol A, a triterpinoid isolated from Poncirus trifoliata (Rutaceae) through inhibition of NF‐κB signalling in mice

Phytotherapy Research. 2019; 33:327–341. USA

February, 2019

3.766

14.  A Khan, Salman Khan, YS Kim. Insight of Pain modulation: nociceptors sensitization and therapeutic targets.

Current Drug Targets.

doi: 10.2174/1389450120666190131114244

January 30, 2019

2.642

15.  A Atiq, B Shal, M Naveed, A Khan, J Ali, S Zeeshan. SD. Al-Sharari, YS Kim, Salman Khan. Diadzein ameliorates 5-fluorouracil-induced intestinal mucositis by suppressing oxidative stress and inflammatory mediators in rodents

European Journal of Pharmacology, 843, 15, 292-306

Netherland

January 2019

3.170

16.  S Khalid, MA Zahid, H Ali, YS Kim, Salman Khan. Biaryl scaffold-focused virtual screening for anti-aggregatory and neuroprotective effects in Alzheimer’s disease.

BMC Neuroscience 13;19(1):74. doi: 10.1186/s12868-018-0472-6

November, 2018

2.620

17.  M Zia ullah, A Khan, R Afridi,  H Rasheed,  S Khalid, M Naveed,  H Ali YS Kim,  Salman Khan. Attenuation of inflammatory pain by Puerarin in animal model of inflammation through inhibition of pro-inflammatory mediators.

International Immunopharmacology-61:306-316 (USA)

2018

3.361

 

18.  H Rasheed, R Afridi, A Khan, M Z Ullah, S Khalid, A Atiq, H Kashif, M Naeem Ahmed, Y S Kim, Salman Khan. Anti-inflammatory, anti-rheumatic and analgesic activities of 2-(5-mercapto-1,3,4-oxadiazol-2-yl)-N-propylbenzenesulphonamide (MOPBS) in rodents.

Inflammopharmacology; 26:1037–1049. (UK)

2018

3.838

19.  B Shal, W Ding, H Ali, YS Kim, Salman Khan. Anti-neuroinflammatory potential of natural products in attenuation of Alzheimer’s disease.

 

Frontiers in Pharmacology- 9, Article 548. doi: 10.3389/fphar.2018.00548. (Switzerland).

2018

3.845

20.  S Khalid, M Z. Ullah, A Khan, R Afridi, H Rasheed, A Khan, H Ali, YS Kim, and Salman Khan Antihyperalgesic Properties of Honokiol in Inflammatory Pain Models by Targeting of NF-κB and Nrf2 Signaling..

 

Frontiers in Pharmacology, Vol 09 /article-140. doi: 10.3389/fphar.2018.00140. (Switzerland)

2018

3.845

21.  F Shahid, M Ismail, Salman Khan. Assessment of quality of life in post burn survivors: A cross-sectional single-center first validation study from Pakistan.

Burns Open, 2 (1), 35-42.(USA)

 

2018

00

22.  Salman Khan, RJ Choi, JH Lee, YS Kim. Attenuation of neuropathic pain and neuroinflammatory responses by a pyranocoumarin derivative in animal and cellular models.

 

European Journal of Pharmacology 774, 95–104. (Netherland)

2016

3.170

23.  Salman Khan, O Shehzad, R Li, MS Cheng, and YS Kim. Pharmacological mechanism underlying anti-inflammatory properties of two structurally divergent coumarins through inhibition of pro-inflammatory enzymes and cytokines.

 

Journal of Inflammation, 29; 12:47. (UK)

2015

2.662

24.  Salman Khan, O. Shehzad, J. Chun, R, J. Choi, M. N. Islam, J. S. Choi, and Y. S. Kim. Anti-hyperalgesic and anti-allodynic activities of capillarisin via suppression of inflammatory signaling in animal model.

 

Journal of Ethnopharmacology, 28;152(3):478-86). (Netherland)

2014

3.414

25.  Salman Khan, O. Shehzad, K. J. Lee, A. Tosun, Y. S. Kim Anti-inflammatory properties of samidin from Sesli resinosm though suppression of NF-κB and AP-1-mediated-genes in LPS-stimulated RAW 264.7 cells..

 

Archive of Pharmacal Research, 37(11):1496-503. (South Korea)

2014

2.458

26.  R. J Choi, J. Chun, Salman Khan and Y. S. Kim. Desoxyrhapontigenin, a potent anti-inflammatory phytochemical, inhibits LPS-induced inflammatory responses via suppressing NF-κB and MAPK pathways in RAW 264.7 cells.

International Immunopharmacology, 18,182–190. (USA)

2014

3.361

27.  A Tosun, Salman Khan, YS Kim, á Calín-Sánchez, X Hysenaj and Aá Carbonell-Barrachina. I Essential Oil Composition and Anti-Inflammatory Activity of Salvia officinalis L (Lamiaceae) in Murin Macrophages.

 

Tropical Journal of Pharmaceutical Research, 13 (6): 937-942. (Africa).

2014

0.439

28.  Salman Khan, O. Shehzad, J. Chun, Y. S. Kim Mechanism underlying anti-hyperalgesic and anti-allodynic properties of anomalin in both acute and chronic inflammatory pain models in mice through inhibition of NF-κB, MAPKs and CREB signaling cascades.

 

European Journal of Pharmacology, 718, 448–458. (Netherland)

2013

3.170

29.  Salman Khan, R. J. Choi, O. Shehzad, H. P. Kim, M. N. Islam, J. S. Choi, and Y. S. Kim. IF: Molecular mechanism of capillarisin-mediated inhibition of MyD88/TIRAP inflammatory signals in in vitro and in vivo experimental models.

 

Journal of Ethnopharmacology, 145, 626–637. (Netherland)

2013

3.414

30.  Salman Khan and Y. S. Kim. Molecular mechanism of inflammatory signaling and predominant role of Saposhnikovia divaricata as anti-inflammatory potential.

 

Natural Product Sciences, 19(2): 1-7. (Korea)

2013

00

31.  O. Shehzad, Salman Khan, I.J.  Ha, Y. Park, A. Tosun, Y. S. Kim.Application of stepwise gradients in counter-current chromatography: A rapid and economical strategy for the one-step separation of eight coumarins from Seseli resinosum.

 

Journal of Chromatography A, 1310 66–73. (USA)

2013

3.858

32.  Salman Khan, A. Shehzad, O. Shehzad, and E. A Al-Suhaimi. Inpatient antibiotics pharmacology and physiological use in Hayatabad Medical Complex, Pakistan.

 

International Journal of Physiology, Pathophysiology and Pharmacology, 5(2):120-127). (USA)

2013

00

33.  R. J. Choi, T. M. Ngoc, K. Bae, H. J. Cho , D. D. Kim, J. Chun, Salman Khan, Y. S. Kim.  Anti-inflammatory properties of anthraquinones and their relationship with the regulation of P-glycoprotein function and expression.

 

European Journal of Pharmaceutical Sciences, 48, 272–281. (Netherland)

2013

3.532

34.  Salman Khan, O. Shehzad, E. R. Woo, S. S. Kang, S. W. Baek, J. Kim, Y. S. Kim. Anti-inflammatory Mechanism of 15,16-Epoxy-3α-hydroxylabda-8,13(16),14-trien-7-one via Inhibition of LPS-Induced Multicellular Signaling Pathways.

 

Journal of Natural Products, 75, 67−71. (USA)

2012

4.257

35.  J. Chun , R. J. Choi, Salman Khan, D. S. Lee, Y.C Kim, Y. J Nam,, D. U Lee, Y. S. Kim. Alantolactone suppresses inducible nitric oxide synthase and cyclooxygenase-2 expression by down-regulating NF-κB, MAPK and AP-1 via the MyD88 signaling pathway in LPS-activated RAW 264.7 cells.

International Immunopharmacology, 14(4):375-83. (USA)

2012

3.361

36.  O. Shehzad, Salman Khan, I. J. Ha, Y. Park, Y. S. Kim. Rational development of a selection model for solvent gradients in single-step separation of ginsenosides from Panax ginseng using high-speed counter-current chromatography.

 

Journal of Separation Science, 35, 1462–1469. (USA)

2012

2.516

37.  Shehzad, Salman Khan, Y. S Lee. Curcumin molecular targets in obesity and obesity related cancer.

 

Future Oncology, 8(2), 1-12.  (USA)

2012

2.279

38.  Salman Khan, E. M. Shin, Y. H. Jung, J. Kim, A. Tosun, Y. S. Kim. Suppression of LPS-induced inflammatory and NF-κB responses by anomalin in RAW 264.7 macrophages.

 

Journal of Cellular Biochemistry, 112(8):2179-88. (USA)

2011

3.448

39.  Salman Khan, R. J. Choi, Dong-Ung Lee, Y. S. Kim. Sesquiterpenes derivatives isolated from Cyperus rotundus L. inhibits inflammatory signaling mediated by NF-κB pathway.

Natural Product Sciences, 17(3): 250-255. (Korea)

 

2011

00

40.  O. Shehzad, Salman Khan, T. Khan and JK Park. Physicochemical and mechanical characterization of bacterial cellulose produced with an excellent productivity in static conditions using a simple fed-batch cultivation strategy

 

Carbohydrate Polymers, 82, 173-180. (USA)

2010

6.044

41.  A. Shehzad, Salman Khan, O. Shehzad, and Y. S. Lee. Curcumin therapeutic promises and bioavailability in colorectal cancer.

 

Drugs of Today, 46(7): 523. (Spain)

2010

1.074

42.  O. Shehzad, Salman Khan, T. Khan, and JK. Park Production of bacterial cellulose in static conditions by a simple fed-batch cultivation strategy.

 

Korean Journal of Chemical Engineering, Korean J. Chem. Eng., 26(6), 1689-1692 (Korea)

2009

2.476

43.  J. K. Park, O. Shehzad, T. Khan, Salman Khan. Production of bacterial cellulose by G.hasenii using a new bioreactor equipped with centrifugal impellers.

 

Journal of Biotechnology, 136S, S460–S495. (USA)

2008

3.163

44.  T. Khan, Salman Khan, J. K. Park. Simple fed-batch cultivation strategy for the enhanced production of single-sugar glucuronic acid-based oligosaccharides by a cellulose-producing Gluconacetobacter strain.

 

Biotechnology and Bioprocess Engineering, 13, 240-247. (Korea)

2008

1.438

45.  J. H. Ha, O. Shehzad, Salman Khan, S.Y. Lee, J. W. Park, T. Khan, J.K. Park. Production of bacterial cellulose by a static cultivation using the waste from beer culture broth, Production of bacterial cellulose by a static cultivation using the waste from beer culture broth.

 

Korean Journal of Chemical Engineering. 25(4), 812-815.

2008

2.476

ORAL PRESENTATIONS/INVITED SPEAKERS/PLENARY LECTURES

1.      Salman Khan. Approach toward new drug development based on pharmacological evaluation from naturally isolated compounds. Proceeding of the 47th Annual Meeting of the Korean Society of Pharmacognosy, The 10th KSP-JSP-CJP joint symposium, Ehwa Women University, Seoul, December 22-23, 2018, South Korea

2.      Salman Khan. Predominant role of vascular dysfunction and potential of anti-inflammation in alleviation of neuropathic pain. Asia PharmII (The 2nd Asian conference of Pharmaceutical Sciences, Jun 2-22, 2017, Seoul, Korea.

3.      Salman Khan, RJ Choi, JH Lee, YS Kim. Attenuation of neuropathic pain and neuroinflammatory responses by a pyranocoumarin derivative, anomalin in animal and cellular models. Proceeding of the 46th Annual Meeting of the Korean Society of Pharmacognosy, Seoul, December 03, 2015, South Korea.

4.      Salman Khan, R. J. Choi, O. Shehzad, H. P. Kim, M. N. Islam, J. S. Choi, and Y. S. Kim. Molecular mechanism of capillarisin-mediated inhibition of MyD88/TIRAP inflammatory signaling and its anti-hyperalgesic effect in an inflammatory pain models. 11th CGCM meeting, August 20~24, 2012, Macau. 

5.      Salman Khan, E. M. Shin, Y. H. Jung, J. Kim, A. Tosun, Y. Shik Kim. Anomalin, pyranocoumarin inhibits LPS-induced expression of inflammatory mediators via NF-κB and MAP-kinase signaling pathways. 10th CGCM meeting August 26~ 28, 2011, Shanghai, China.

6.      Salman Khan, E. M. Shin, Y. H. Jung, J. Kim, Y. Shik Kim. Suppression of LPS-induced inflammatory and NF-κB responses by anomalin isolated from the root of Saphoshnikovia divaricata in RAW 264.7 macrophages. December 22-24, 2010 (Tokoshima), Japan.

7.      Salman Khan, E. M. Shin, D-U. Lee, Y. S. Kim. Bioactivity guided evaluation of sesquiterpenes as an anti-inflammatory activity isolated from Cyperus rotundus L: Effect of chemical structures and cellular signaling pathway. 9th CGCM meeting, 2010. Hong Kong.

 

POSTER PRESENTATIONS/ CONFERENCES

 

1.      S Khalid, M Ziaullah, A Khan, R Afridi, h Rasheed, A Khan, H Ali, YS Kim, Salman Khan. Antihyperalgesic and antiallodynic properties of honokiol in acute and chronic models of inflammatory pain. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan.

2.      A Khan, M Ziaullah, R Afridi, H Rasheed, S Khalid, H Ullah, YS Kim, Salman Khan. Anti-nociceptive properties of 25-MHA in CFA and carrageenan-induced in animal models. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan

3.      H Rasheed, R Afridi, A Khan, M Ziaullah, S Khalid, A Atiq, H kashif, MN Ahmad, YS kim, Salman Khan. Anti‑infammatory and analgesic activities of 2‑(5‑me rcapto‑1,3,4‑oxadiazol‑2‑yl)‑N‑propylbenzenesulphonamide (MOPBS) in rodents. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan.

4.      A Atiq, B Shal, M Naveed, A Khan, S Zeeshan, Salman Khan. Pharmacological evaluation of Silver sulfadiazine nanoparticles loaded Alovera encapsulated film on animal mode of wounds. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan.

5.      M Naveed, S Zeeshan, A Khan, B Shal, A Atiq, Salman Khan. Anti-inflammatory, analgesic and antipyretic activities of newly synthesized hetroleptic palladium(II) complexes. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan.

6.      S Zeeshan, M Naveed, A Khan, B Shal, H Rasheed, Salman Khan. Anti-inflamamtory and analgesic effect of novel palladium (II) complexes on animal models. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan

7.       A Khan, B Shal, M Naveed, A Atiq, S Zeeshan, Salman Khan. Matrine ameliorates anxiety and depressive like behavior in carbon tetrachloride and burn-induced animal models. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan.

8.       B Shal, A Khan, M Naveed, A Atiq, S Zeeshan, Salman Khan. Evaluation of pharmacological potential of 25-MHA in LPS and CCl4-induced anxiety and depression models. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan.

9.      R Afridi, H Rasheed, A Khan, S Khalid, Z ullah, B Shal, H Jabeen, YS Kim, Salman Khan. Antihyperalgesic properties of Flavone derivative Poncirin in acute and chronic inflammatory pain models in mice. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan.

10.   M Zeeshan, H Ali, M Arshad, MI Khan, M Mukhtar, Salman Khan. Design. Characterization and kinetics study of Glycyrrhizic acid loaded pH-sensitive PLGA nanoparticles for the potential drug targeting in inflammatory bowel disease. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan

11.  Salman Khan. 2nd international conference on recent innovations in pharmaceutical sciences (ICRIPS-2017), Organized by Riphah Institute of Pharmaceutical Sciences, November 15-16, 2017, Islamabad, Pakistan.

12.  Salman Khan, O. Shehzad, J. Chun, and Y. S. Kim. Mechanism underlying anti-hyperalgesic and anti-allodynic properties of anomalin in both acute and chronic inflammatory pain models in mice through inhibition of NF-κB, CREB and MAPKs signaling cascades. Korean Society of Pharamcognosy 2012. 06. (Seoul, Korea).

13.  Salman Khan, R. J. Choi, O. Shehzad, H. P. Kim, M. N. Islam, J. S. Choi, and Y. S. Kim. Molecular mechanism of capillarisin-mediated inhibition of MyD88/TIRAP inflammatory signaling and its anti-hyperalgesic effect in an inflammatory pain models. 11th CGCM meeting August 20~24, 2012, Macau. 

14.  Salman Khan, E. M. Shin, S. W. Baek, J. Kim, Y. S. Kim. Novel labdan diterpene derivative isolated from Leonurus japonicum as a function of anti-inflammatory activity in LPS-stimulated RAW 264.7 cells. 9th CGCM meeting, 2010, Hong Kong.

15.  Salman Khan, E. M. Shin, Y. H. Jung, J. Kim, Y. S. Kim. Anti-inflammatory and anti-NF-κB effects of anomalin isolated from the root of Saposhnikovia divaricata in LPS-stimulated RAW264.7 macrophages.  9th CGCM meeting, 2010, Hong Kong.

16.  Salman Khan, E. M. Shin, Y. H. Jung, J. Kim, Y. Shik Kim. Suppression of LPS-induced inflammatory and NF-κB responses by anomalin isolated from the root of Saphoshnikovia divaricata in RAW 264.7 macrophages. December 22-24, 2010 (Tokoshima), Japan.

17.  Salman Khan, O. Shehzad, T. Khan, J. K. Park, Investigation of flow pattern and volumetric oxygen transfer coefficient (KLa) for new bioreactors equipped with centrifugal impellers. Korean Society of Biotechnology and Bioprocess engineering (KSBB), 2008, Jinju S. Korea. 

18.  Salman Khan, O. Shehzad, T. Khan, J. K. Park, Treatment of Brewery Waste for the Improved Production of Bacterial Cellulose by a Gluconacetobacter Strain, Young Asian Biochemical Engineers’s Community 2007, (YABEC), Japan.

19.  Salman Khan, O. Shehzad, T. Khan, J. K. Park, Evaluation of Autolyzed waste of beer fermentation broth as a basal medium for the production of bacterial cellulose and oligosaccharides Gluconacetobacter hansenii, Korean Institute of Chemical Engineers 2007 (KIChE-2007), Daejon, South Korea.

20.  Salman Khan, O. Shehzad, T. Khan, J. K. Park, Production and structure feature of bacterial cellulose using nano-bubble system, Young Asian Biochemical Engineers’s Community 2008 (YABEC-2008), Japan.

21.  Salman Khan, O. Shehzad, T. Khan, J. K. Park, Production of bacterial cellulose using waste from beer fermentation broth in shaking cultivation, Korean Society of Biotechnology and Bioprocess engineering (KSBB), 2008, Jeju do, S.Korea,.

 

22.   O. Shehzad, Salman Khan, T. Khan, J. K. Park, Production of Bacterial Cellulose membrane by G. hasenii using fed batch cultivation. (Korean Society of Biotechnology and Bioprocess engineering (KSBB), 2008, Jinju S. Korea.

 

23.  O. Shehzad, Salman Khan, T. Khan, J. K. Park, Production of bacterial cellulose in fed batch cultivation using waste from beer fermentation broth. Korean Institute of Chemical Engineers (KIChE-2008), Pusan, Oct 22, 2008, South Korea.

 

24.  O. Shehzad, Salman Khan, T. Khan, J. K. Park, Physico-Chemico-Mechanical characteristics of bacterial cellulose produced in fed batch cultivation using waste from beer fermentation broth. Korean Institute of Chemical Engineers (KIChE-2008), Pusan, Oct 22, 2008, South Korea.

 

 

ii. Courses and Workshops/Trainings

 

1.      3-days national workshop on “Nanomedicine”: Advancement & Challenges in Pakistan. Organized by HEC-QAU, November 27-29, 2017.

2.      “Nanomedicine: Novel Approaches in Drug Delivery”. at Kohat University of Science and Technology, Kohat, Pakistan, 11-12 April 2017.

3.      Integrated clinical pharmacy education, practice & Research: Bridging the Gap- Organized by COMSTECH from 22-24 Feb, 2016.

4.      3-days workshop on “Teaching and Research Skills” Organized by HEC-QAU, October 18-20, 2016.

Salman Khan, Y S Kim. Pharmacological Screening of KFDA samples (natural products) for anti-inflammatory, anti-nociceptive and behavioral pharmacological activities. Joint project between College of Pharmacy, Seoul National University, Seoul, Korea and Department of Pharmacy, QAU. From March 15, 2015~ March 10, 2019), Funded by National Research Foundation (NRF), South Korea.

Salman Khan (PI), Gul Majid Khan (Co-PI); “Evaluation of phenolic compounds effect on streptozotocin-induced diabetes and related neuropathic pain model in mice”, 2015-2016 HEC, Pakistan (Rs. 419000) Completed)

Salman Khan (Co-PI), Ji Zhang.  Potential of anti-inflammation in relieving diabetic neuropathy. Neuroinflammation Training Program, McGill University, Montreal, Quebec, Canada, April 01, 2014~ April 30, 2015. (40000USD) Completed.

 Salman Khan (PI), YS Kim (Co-PI). BK-21-plus, College of Pharmacy, Seoul National University, Seoul, South Korea, 2013~ 2014 (30000USA) Completed.

Salman Khan (PI), Hussain Ali (Co-PI). Therapeutic potential of anti-inflammation in attenuation of neurodegenerative diseases: molecular approach toward specific targets (NRPU-submitted to HEC, Pakistan)

Hussain Ali (PI), Salman Khan (Co-PI); “Preparation and characterization of drug loaded PLGA/pH- sensitive PLGA-nanoparticles for therapeutic applications”, HEC, Pakistan (Submitted)



Quaid-i-Azam University Islamabad, 45320, Pakistan.
Tel: +92-51 9064 0000, Email:webmaster@qau.edu.pk